scholarly journals Randomized, Double-Blind, Placebo-Controlled Trial of the mGlu2/3 Negative Allosteric Modulator Decoglurant in Partially Refractory Major Depressive Disorder

2020 ◽  
Vol 81 (4) ◽  
Author(s):  
Daniel Umbricht ◽  
Markus Niggli ◽  
Patricia Sanwald-Ducray ◽  
Dennis Deptula ◽  
Rema Moore ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Allosteric Modulator ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Negative Allosteric Modulator

scholarly journals A Randomized, Double-Blind, Placebo-Controlled Trial of Escitalopram in Patients with Asthma and Major Depressive Disorder

2018 ◽  
Vol 6 (5) ◽  
pp. 1604-1612 ◽  
Author(s):  
E. Sherwood Brown ◽  
Nasreen Sayed ◽  
Erin Van Enkevort ◽  
Alexandra Kulikova ◽  
Alyson Nakamura ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo

A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder

2013 ◽  
Vol 74 (07) ◽  
pp. e636-e641 ◽  
Author(s):  
Cristina Cusin ◽  
Nadia Iovieno ◽  
Dan V. Iosifescu ◽  
Andrew A. Nierenberg ◽  
Maurizio Fava ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Treatment Resistant ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo

L-Carnosine combination therapy for major depressive disorder: A randomized, double-blind, placebo-controlled trial

2020 ◽  
Vol 267 ◽  
pp. 131-136 ◽  
Author(s):  
Behin Araminia ◽  
Mohammadreza Shalbafan ◽  
Amirhosein Mortezaei ◽  
Elham Shirazi ◽  
Salomeh Ghaffari ◽  
...  
Keyword(s):  
Major Depressive Disorder ◽  
Combination Therapy ◽  
Depressive Disorder ◽  
Controlled Trial ◽  
Major Depressive ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document